5Allred DC,Harvey JM,Berardo M,et al.Prognostic and predictive factors in breast cancer by immunohistochemical analysis.Mod Pathol,1998,11(2):155-168.
6Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for Human Epidermal Growth Factor Receptor 2 testing in breast cancer.Arch Pathol Lab Med,2007,131(1):1843.
7Hull DF,Clark GM,Osborne CK,et al.Multiple estrogen receptor assays in human breast cancer.Cancer Res,1983,43(1):413-416.
8Mobbs BG,Fish EB,Pritchard KI.Estrogen and progesterone receptor content of primary and secondary breast carcinoma:influence of time and treatment.Eur J Cancer Clin Oncol,1987,23(6):819-826.
9Franco A,Col N,Chlebowski RT,et al.Discordance in estrogen and progestin receptor status between primary and etastatic breast cancer:A meta-analysis.J Clin Onco,2004,122(14S):539.
10Gancberg D,Di Leo A,Cardoso F,et al.Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites.Ann Oncol,2002,13(7):1036-1043.
